Risk of tumour recurrence following curative treatment of hepatocellular carcinoma.
Saved in:
| Title: | Risk of tumour recurrence following curative treatment of hepatocellular carcinoma. |
|---|---|
| Authors: | Bengtsson B; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden., Pak G; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden., Vaz J; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.; School of Public Health and Community Medicine, Sahlgrenska Academy, University of GothenburgGothenburg, Sweden., Widman L; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden., Hagström H; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.; Division of Hepatology, Department of Upper GI Diseases, Karolinska University Hospital, Stockholm, Sweden. |
| Source: | Scandinavian journal of gastroenterology [Scand J Gastroenterol] 2025 Dec; Vol. 60 (12), pp. 1192-1195. Date of Electronic Publication: 2025 Sep 29. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 0060105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1502-7708 (Electronic) Linking ISSN: 00365521 NLM ISO Abbreviation: Scand J Gastroenterol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
